Loading organizations...
Kiro, based in Paris, France, develops an AI-powered digital health platform that standardizes and analyzes clinical biology lab test results for healthcare providers and patients. The platform provides personalized results and real-time clinical decision support for prevention and diagnosis, leveraging medical-grade AI and cloud technology. It serves millions of users through partnerships with laboratories, hospitals, and physicians. Kiro has raised over €17 million in total funding, including a €13.8 million Series A round in March 2023. This round was led by Sofinnova Partners, with participation from Bpifrance and Kurma Partners, and Edward Kliphuis serves on its board. The company was founded in 2019 by Alexandre Guenoun. Its business model centers on venture-funded SaaS platform serving healthcare providers, generates revenue through partnerships with laboratories, hospitals, and physicians.
Kiro has raised $15.0M across 1 funding round.
Kiro has raised $15.0M in total across 1 funding round.
Kiro has raised $15.0M in total across 1 funding round.
Kiro's investors include Edward Kliphuis, Bpifrance, Kurma Partners, Propulia Capital.
Kiro has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in March 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 31, 2023 | $15M Series A | Edward Kliphuis | Bpifrance, Kurma Partners, Propulia Capital | Announced |
